Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related AKBA
Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos
48 Biggest Movers From Yesterday
Related AI
26 Stocks Moving In Thursday's Pre-Market Session
Benzinga's Top Upgrades, Downgrades For August 1, 2017

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Latest Ratings for AKBA

DateFirmActionFromTo
Dec 2017PiperJaffrayInitiates Coverage OnOverweight
Dec 2017BTIG ResearchInitiates Coverage OnBuy
Oct 2017MizuhoInitiates Coverage OnBuy

View More Analyst Ratings for AKBA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AI + AKBA)

View Comments and Join the Discussion!